Skip to main content
. 2012 Jul 11;4(4):649–654. doi: 10.3892/etm.2012.637

Figure 5.

Figure 5

Effect of embelin on the HepG2 human hepatocellular carcinoma cell cycle. After different doses of embelin were administered to HepG2 cells for 48 h, (A) flow cytometry was used to analyze the cell cycle; (B) the histogram shows the HepG2 cell cycle (%). *P<0.05, **P<0.01. The data are representative of three independent experiments.